Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P P Sfikakis

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Lupus|July 26, 2002
CD40L overexpression on T cells and monocytes from patients with systemic lupus erythematosus is resistant to calcineurin inhibitionC G Katsiari, S N C Liossis, A M Dimopoulos, et al.
Leukemia|October 4, 2013
Progressive changes in chromatin structure and DNA damage response signals in bone marrow and peripheral blood during myelomagenesisM Gkotzamanidou, E Terpos, C Bamia, et al.
Postgraduate Medical Journal|October 1, 1994
The association of systemic lupus erythematosus and myasthenia gravisG Vaiopoulos, P P Sfikakis, V Kapsimali, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 27, 1998
Macrovascular disease of coronaries and cerebral arteries in streptozotocin-induced diabetic rats. A controlled, comparative studyM E Mavrikakis, P P Sfikakis, D Kontoyannis, et al.
Scandinavian Journal of Rheumatology|February 21, 2018
Secukinumab after anti-tumour necrosis factor-α therapy: a phase III study in active rheumatoid arthritisE Dokoupilová, J Aelion, T Takeuchi, et al.
Clinical and Experimental Rheumatology|April 19, 2012
Abnormal spatial QRS-T angle, a marker of ventricular repolarisation, predicts serious ventricular arrhythmia in systemic sclerosisE Gialafos, P Konstantopoulou, C Voulgari, et al.
Arthritis and Rheumatism|May 29, 2007
Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosisP P Sfikakis, C Papamichael, K S Stamatelopoulos, et al.
Clinical and Experimental Rheumatology|November 14, 2007
Infliximab treatment-induced formation of autoantibodies is common in Behçet's diseaseA Elezoglou, N Kafasi, P H Kaklamanis, et al.
Clinical and Diagnostic Laboratory Immunology|September 25, 1997
Soluble interleukin-2 receptor is a thyroid hormone-dependent early-response marker in the treatment of thyrotoxicosisR C Smallridge, G C Tsokos, K D Burman, et al.
Leukemia & Lymphoma|October 21, 2003
13q deletion in chronic lymphocytic leukemia: characterization of E4.5, a novel chromosome condensation regulator-like guanine nucleotide exchange factorE E Solomou, P P Sfikakis, P Kotsi, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Lupus|July 26, 2002
CD40L overexpression on T cells and monocytes from patients with systemic lupus erythematosus is resistant to calcineurin inhibitionC G Katsiari, S N C Liossis, A M Dimopoulos, et al.
Leukemia|October 4, 2013
Progressive changes in chromatin structure and DNA damage response signals in bone marrow and peripheral blood during myelomagenesisM Gkotzamanidou, E Terpos, C Bamia, et al.
Postgraduate Medical Journal|October 1, 1994
The association of systemic lupus erythematosus and myasthenia gravisG Vaiopoulos, P P Sfikakis, V Kapsimali, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 27, 1998
Macrovascular disease of coronaries and cerebral arteries in streptozotocin-induced diabetic rats. A controlled, comparative studyM E Mavrikakis, P P Sfikakis, D Kontoyannis, et al.
Scandinavian Journal of Rheumatology|February 21, 2018
Secukinumab after anti-tumour necrosis factor-α therapy: a phase III study in active rheumatoid arthritisE Dokoupilová, J Aelion, T Takeuchi, et al.
Clinical and Experimental Rheumatology|April 19, 2012
Abnormal spatial QRS-T angle, a marker of ventricular repolarisation, predicts serious ventricular arrhythmia in systemic sclerosisE Gialafos, P Konstantopoulou, C Voulgari, et al.
Arthritis and Rheumatism|May 29, 2007
Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosisP P Sfikakis, C Papamichael, K S Stamatelopoulos, et al.
Clinical and Experimental Rheumatology|November 14, 2007
Infliximab treatment-induced formation of autoantibodies is common in Behçet's diseaseA Elezoglou, N Kafasi, P H Kaklamanis, et al.
Clinical and Diagnostic Laboratory Immunology|September 25, 1997
Soluble interleukin-2 receptor is a thyroid hormone-dependent early-response marker in the treatment of thyrotoxicosisR C Smallridge, G C Tsokos, K D Burman, et al.
Leukemia & Lymphoma|October 21, 2003
13q deletion in chronic lymphocytic leukemia: characterization of E4.5, a novel chromosome condensation regulator-like guanine nucleotide exchange factorE E Solomou, P P Sfikakis, P Kotsi, et al.
Pageof 11